Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:19.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:56.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible changes to study content.
    Difference
    0.1%
    Check dated 2026-03-12T02:22:37.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag was added and the earlier Revision: v3.4.1 funding-status notice was removed, which are maintenance updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:47:05.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and NIH operations status; updated the site to version 3.4.1 and removed the 3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:14:37.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    A glossary toggle was added to the page. Minor metadata updates were made, including the label 'Last Update Submitted that Met QC Criteria', capitalization of 'No FEAR Act data', and the revision note 'v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T05:10:04.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.